Andean Court Upholds Colombia HIV Drug License
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Andean Community Court upheld Colombia's compulsory license for an HIV medicine issued two years ago.
- Colombia was found to have properly justified the public‑interest reasons and set an appropriate expiration date for the license.
- ViiV Healthcare is the manufacturer of the HIV drug subject to the compulsory license.
- Andean Community Court determined that Colombia did not breach regional regulations because the license served a public‑interest purpose.
- Colombia Health Ministry said the government complied with its obligation to determine the license duration.
Why it matters: The ruling lets Colombia keep the HIV drug at lower cost, expanding access for patients while confirming that public‑interest compulsory licensing complies with Andean law, limiting ViiV Healthcare’s monopoly profits.
Ask SkimNews
